Article Feature: InStride Health Sustains Outstanding Clinical Results in Third Annual Outcomes Report; Announces State Expansion Across East Coast

InStride Health’s 2026 Annual Clinical Outcomes Report found that 97% of patients demonstrated clinical improvement, with significant reductions in anxiety and depression symptoms across more than 3,600 episodes of care. The company also nearly doubled patient enrollment in 2025 while maintaining strong outcomes and announced expansion into five new East Coast markets, including Washington, D.C., Florida, and Georgia. NovaOne VP of Client & Provider Success Rachel Goldberg emphasized that InStride’s scalable, evidence-based care model is helping health plans improve access to high-quality pediatric mental health care while delivering low hospitalization rates and meaningful outcomes for families.